Accumulation of insoluble conformationally altered hyperphosphorylated tau occurs as part of the pathogenic process in Alzheimer’s disease (AD) and other tauopathies. The gene discussed is MAPT; the disease is early-onset autosomal dominant Alzheimer disease.